Trial intelligence / Profile preview

IV vs Oral Iron for Iron Deficiency Anemia in Pregnancy

NCT07384663Phase 1Completed

Sponsor
Azam Medical Services
Start
Jun 2025
Primary completion
Nov 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised, open-label trial in iron deficiency anemia (IDA) comparing IV Ferric carboxymaltose with Oral polysaccharide iron complex (2 arms). Primary endpoint: Blood Haemoglobin Levels at 4 weeks. Started Jun 2025; status: completed.

02

Drugs

ferric carboxymaltoseiron polysaccharide complex
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT07384663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07384663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call